Literature DB >> 18362832

Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis.

Hong-Bin Liu1, Nai-Qiang Cui, Qian Wang, Dong-Hua Li, Xiao-Ping Xue.   

Abstract

OBJECTIVE: To investigate the effects of sphingosine-1-phosphate (S1P) and its analogue FTY720 on the lung injury induced by acute necrotizing pancreatitis in rats.
METHODS: Acute necrotizing pancreatitis was induced by retrogradely injection of 5% sodium taurocholate of biliopancreatic duct in rats. Sphingosine-1-phosphate (100 microg/kg) or FTY720 (1 mg/kg) was administered immediately after the model induction by peritoneal injection. Six hours after the model induction, bronchoalveolar lavage protein concentration, total cell count, polymorphonuclear neutrophil percentage, proinflammatory cytokines (interleukin 1beta, interleukin 6, and tumor necrosis factor alpha), nuclear factor kappaB activation of alveolar macrophages, and lung myeloperoxidase (MPO) activity were examined. Serum amylase and lipase were tested. In addition, histopathological changes of the pancreas and lung were observed.
RESULTS: Bronchoalveolar lavage protein concentration, total cell count, PMN percentage, proinflammatory cytokines, nuclear factor kappaB activation, lung capillary leakage, and lung myeloperoxidase were all reduced significantly in both S1P and FTY720 groups. The pulmonary pathological injury in both S1P and FTY720 groups was ameliorated obviously. Nevertheless, the serum amylase, lipase, and the pancreatic pathological damages were not decreased.
CONCLUSIONS: Sphingosine-1-phosphate and its analogue FTY720 significantly decreased pulmonary inflammation and injury in a rat model of acute lung injury caused by acute necrotizing pancreatitis and may represent a novel therapeutic strategy for the acute necrotizing pancreatitis-associated lung injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362832     DOI: 10.1097/MPA.0b013e31815f3905

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  24 in total

Review 1.  Endothelial FAK as a therapeutic target in disease.

Authors:  Giovanni A Infusino; Jeffrey R Jacobson
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

Review 2.  Lipid mediators in the regulation of endothelial barriers.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Tissue Barriers       Date:  2017-10-30

3.  Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

Authors:  Barry S Shea; Sarah F Brooks; Benjamin A Fontaine; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

Review 4.  Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Proc Am Thorac Soc       Date:  2012-07

5.  FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.

Authors:  Lichun Wang; Saad Sammani; Liliana Moreno-Vinasco; Eleftheria Letsiou; Ting Wang; Sara M Camp; Robert Bittman; Joe G N Garcia; Steven M Dudek
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

Review 6.  Essential role of monocytes and macrophages in the progression of acute pancreatitis.

Authors:  Pratima Shrivastava; Madhav Bhatia
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

Review 7.  The role of sphingolipids in endothelial barrier function.

Authors:  Peter L Jernigan; Amy T Makley; Richard S Hoehn; Michael J Edwards; Timothy A Pritts
Journal:  Biol Chem       Date:  2015-06       Impact factor: 3.915

8.  Clinical observation of immunity in patients with secondary infection from severe acute pancreatitis.

Authors:  YinFeng Shen; Nai-Qiang Cui
Journal:  Inflamm Res       Date:  2012-04-01       Impact factor: 4.575

9.  FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.

Authors:  Qing Liu; Lapo Alinari; Ching-Shih Chen; Fengting Yan; James T Dalton; Rosa Lapalombella; Xiaoli Zhang; Rajeswaran Mani; Teresa Lin; John C Byrd; Robert A Baiocchi; Natarajan Muthusamy
Journal:  Clin Cancer Res       Date:  2010-05-11       Impact factor: 12.531

10.  Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema.

Authors:  Khalil J Diab; Jeremy J Adamowicz; Krzysztof Kamocki; Natalia I Rush; Jana Garrison; Yuan Gu; Kelly S Schweitzer; Anastasia Skobeleva; Gangaraju Rajashekhar; Walter C Hubbard; Evgeny V Berdyshev; Irina Petrache
Journal:  Am J Respir Crit Care Med       Date:  2009-12-03       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.